Neuroblastoma (NBL), one of the most common childhood solid tumors, has a distinct nature in different prognostic subgroups: NBL in patients under 1 year of age usually regresses spontaneously, whereas that in patients over 1 year of age often grows aggressively and eventually kills the patient. To understand the molecular mechanism of biology and tumorigenesis of NBL, we decided to perform a comprehensive approach to unveil the gene expression profiles among the NBL subsets. We constructed the subset-specific oligo-capping cDNA libraries from the primary NBL tissues with favorable (F: stage 1, high expression of TrkA and a single copy of MYCN) and unfavorable (UF: stage 3 or 4, decreased expression of TrkA and MYCN amplification) characteristics and randomly cloned 4654 cDNAs. Among 4243 cDNAs sequenced successfully, 1799 (42.4%) were the genes with unknown function. Excluding the housekeeping genes, an expression profile of each subset was extremely different. To determine the genes expressed differentially between F and UF subsets, we performed semiquantitative reverse transcriptase (RT)-PCR for each of the 1842 independent genes using RNA obtained from 16 F and 16 UF NBLs as template. This revealed that 278 genes were highly expressed in the F subset as compared to the UF one, while, surprisingly, only 27 genes were expressed at higher levels in the UF rather than the F subset. These differentially expressed genes included 194 genes with unknown function. Many of the genes expressed at high levels in the F subset were related to catecholamine biosynthesis, small GTPases, synapse formation, synaptic vesicle transport, and transcription factors regulating differentiation of the neural crest-derived cells. On the other hand, the genes expressed at high levels in the UF subset included transcription factors and/or receptors that might regulate neuronal growth and differentiation. The chromosomal mapping of those genes showed some clusters. Thus, our mass-identification and characteriza-Introduction Neuroblastoma (NBL) is a pediatric cancer originating from sympathoadrenal lineage of the neural crest. However, its clinical behavior is enigmatic. It often regresses spontaneously when the tumor occurs in patients less than 1 year of age, while it is usually aggressive when it occurs in those over 1 year of age . Accumulating evidence suggests that the NBL regression is at least in part regulated by developmentally programmed neuronal cell death (PNCD) and/or neuronal differentiation that are similar to the phenomena occurring in normal sympathetic neurons during their development. In contrast, aggressive NBLs continue to grow with enhanced invasiveness and metastasis to the specific regions such as bones and distant lymph nodes.
The recent advances in NBL research have revealed cytogenetic as well as molecular biological bases of this tumor. NBLs in advanced stages often possess a frequent loss of the distal part of the short arm of chromosome 1 (1p), amplification of the MYCN oncogene and gain of chromosome 17q (Brodeur et al., 1984; Caron et al., 1995) . These genetic aberrations are also good prognostic markers. On the other hand, the recent studies have revealed that the biology of NBL is strongly regulated by neurotrophins and their receptors, which is similar to the control of growth, differentiation and programmed cell death in the neural crest-derived cells during the development (Anderson and Axel, 1985; . TRK-A, a high-affinity receptor for nerve growth factor (NGF), has been shown to be expressed in NBLs with favorable prognosis and probably regulate the differentiation and/or regression of the tumor (Nakagawara et al., 1993) . In contrast, TRK-B, encoding a receptor for brain-derived neurotrophic factor and neurotrophin-4/5, is frequently expressed in the tumors with MYCN amplification, which promotes cell survival and increases the invasive ability (Nakagawara et al., 1994; Matsumoto et al., 1995) . Moreover, signaling from the GDNF family and their receptors, Ret and GFRa, appear to play an important role in regulating differentiation of NBL cells (Hishiki et al., 1998) . The other neurotrophic factors, pleiotrophin (PTN) and midkine (MK), are also differentially expressed in different subsets of primary NBL (Nakagawara et al., 1995) . However, those cytogenetic and biological markers are still not always enough to predict the prognosis in certain populations of NBL patients.
To understand the molecular mechanism of genesis and biology of NBL as well as to develop novel diagnostic and therapeutic tools, we have cloned a large number of genes expressed in each subset of primary NBL by using full-length-enriched oligo-capping cDNA libraries. In the present study, we have identified more than 300 genes that are differentially expressed between F and UF subsets, most of which were preferentially expressed in favorable NBLs.
Results
Construction of oligo-capping neuroblastoma cDNA libraries and DNA sequencing Figure 1 shows the scheme of our neuroblastoma cDNA project. The oligo-capping cDNA libraries were constructed from three anonymous primary NBL tissues with favorable characteristics (F: stage 1, high expression of TrkA and a single copy of MYCN) and three NBL tissues with unfavorable biology (UF: stage 3 or 4, low expression of TrkA and amplification of MYCN). Three cDNA library solutions in each group were mixed before randomly picking up 2500 clones from each mixture. Single-run sequencing from both ends of the gene and homology search against the public databases by BLAST program was then performed. We finished sequencing of 2410 clones from the F-NBL library and 2244 clones from the UF-NBL library. The average insert size in both libraries was approximately 2.5 kb. About 53 and 56% of clones were identical to known genes in the F and the UF libraries, respectively. The rest appeared to be novel genes with unknown functions, which included those only hitting to human expressed sequence tags (ESTs), high throughput genome sequences (htgs) and nothing (Genbank release 122, Jan. 2001; Table 1 ).
Expression profile of the known genes in favorable and unfavorable neuroblastomas Table 2 shows the expression profile of the known genes in F and UF NBL libraries. When the housekeeping genes such as polypeptide chain elongation factor, protein synthesis initiation factor and ribosomal proteins were excluded, the nervous system-specific genes were frequently listed up. They included a kinase regulator, 14-3-3 epsilon, playing a role in neural development (McConnell et al., 1995) , P311 abundantly expressed in neuronal cells (Studler et al., 1993) , SCG10 encoding a neuronal growth-associated protein (Anderson and Axel, 1985) and N-cadherin, a calcium-dependent cellcell adhesion glycoprotein (Hirano et al., 1987) . The gene frequently hit among these neuronal genes was 14-3-3 epsilon (9 times in the F library and 7 times in the UF library). Clustering analysis using BLAST homology search program found 1844 of gene groups and 1669 of these were in the F and the UF libraries, respectively. Of these, only 110 gene groups were overlapped between the two libraries, suggesting that the expression profile was markedly different between both libraries. In the UF library, the genes related to protein synthesis like polypeptide chain elongation factor and protein synthesis initiation factor were much more frequent as compared to those in the F library (Table 2) . Notable was a frequency of the DEAD box motif geneDDX1 (69 clones in the UF library) that appeared only once in the F library. As the DDX1 gene was closely linked to and coamplified with the MYCN gene (Amler et al., 1996; Noguchi et al., 1996) , this expression pattern also reflects the nature of the origins of libraries. However, our preliminary study suggested that the difference of the hit numbers of the genes did not necessarily reflect their differential expression between both subsets.
Identification of the genes differentially expressed between favorable and unfavorable neuroblastomas
To identify the genes expressed differentially between the F and UF subsets, all independent clones except the . In total, 1842 independent genes including 1152 unknown genes and 690 known genes from both libraries were surveyed. As a result, we found that at least 305 (16.6%) genes displayed a distinct pattern of differential expression (Table 3) . Among the 305 genes, 278 (109 known and 169 unknown genes) were expressed at higher levels in F than UF NBLs. On the other hand, only 27 genes (two known and 25 unknown genes) were found to be expressed at higher levels in UF than F NBLs (Table 3 ). This RT-PCR screening was repeated at least twice with each gene-specific primer set. Figure 2 shows the representatives of the results of differential screening by semiquantitative RT-PCR. The expression patterns of DDX-1, TrkA, TrkB and MYCN as controls were similar to the previous reports, indicating that our differential screening system using RT-PCR was reliable.
Categorization of the differentially expressed genes
The NBL subset-related genes may include those regulating neuronal growth, differentiation and apoptosis as well as those concerning generation and progression of NBL. We classified the differentially expressed genes into nine categories according to their known functions as shown in Table 4 . The genes preferentially expressed in the F-subset showed an interesting profile as follows. (a) Signaling molecules: This group included certain protein kinases and protein phosphatases, among which protein kinase C zeta (PKCzeta) showed the most distinct F-subset-specific expression pattern. A small GTPase, RAB6B and a GTP-binding protein, RAB3C, functioning in the synaptic vesicles were also found in this group. Three members of dihydropyrimidinase-related genes (DRP-1, -2, -3), which might be involved in axonal outgrowth and pathfinding as a collapsin response mediator (Hamajima et al., 1996) , were also included. Among these family members, DRP-2 showed the most typical F-subset-specific expression. Furthermore, the genes with neural function, like SCG10, stathmin-like-protein RB', neurexophilin, LIS1 and doublecortin were involved. SCG10 was first shown to be the gene induced in neural crest cells when they differentiate into sympathetic neurons and is also known to be a membraneassociated, microtubule-destabilizing protein of neuronal growth cones. Stathmin-like splicing variant RB' gene is a family member of SCG10 and may have a similar function. It showed more distinct difference in its expression pattern than SCG10. (b) Cell cycle-related genes, PRC1 (required for cytokinesis) and tyrosine phosphatase CDC25B (required for entry into mitosis, interacting with 14-3-3 proteins), were included. (c) Cytoskeleton and adhesion molecules: There were some members of the cadherin superfamily like protocadherins alpha 9, beta 12 and gamma A8 (neural cell-cell interaction), laminine alpha4 (neurite outgrowth), peripherin (a type III intermediate filament protein in the mammalian peripheral nervous system) and fibronectin receptor beta subunit (cell-cell connection). Among these transcripts, the most distinct pattern of differential expression was shown by peripherin. (d) Transcriptional regulators: This group included homeodomain-containing transcription factors SHOX2 (short stature homeobox homolog of Drosophila, a member of paired-related family), CUTL1 (Drosophila homeoprotein cut homolog), ZHX1 (zinc-fingers and homeodomain transcription factor 1), chromatin-modifying molecules CHD2 and CHD4 (chromodomain helicase DNA-binding proteins), PHF1 (polycomb-like), MOZ (Monocytic leukemia zinc-finger protein, a putative acetyltransferase), BAZ2B (containing a bromodomain and a PHDfinger) and HIRIP3 (related to chromatin assembly). (e) Protein synthesis, transport and turn over: There were EXO70 and SEC5, Exocyst component proteins 70 and 107 kDa, specifically located at the sites of vesicle fusion (required for exocytosis), proton-coupled divalent metal ion transporters SLC11A3 and SLC25A13, and UbcH7 and Rsp5 (related to ubiquitin-proteasome protein degradation system) in this group. (f) Metabolic enzymes, homeostasis: Drosophila shaker-related potassium voltage-gated channels KCNAB1 and KCNAB2 were found in this category. Catecholamine-related genes, dopamine b-hydroxylase type a (DBH) and monoamine oxidase type A (MAO) displayed a distinct differential expression pattern. The neurotransmitter synthesis-related genes, such as neuronal nicotinic acetylcholine receptor a-7 subunit and b-adrenergic Differential screening of neuroblastoma cDNA libraries M Ohira et al receptor kinase 2 were also found. These differentially expressed genes may reflect the biological status of a favorable subset of NBL which is undergoing neuronal cell growth, migration and differentiation. Interestingly, we also found hematopoiesis-related or leukemia-related genes, like MLLT4 (Trithorax homolog), MTG8-like protein, MOZ and GATA-binding protein FOG2 as differentially expressed genes.
As for the UF-subset-specific (FoUF) genes, only two were reported genes. DDX1 had been already reported to be coamplified with MYCN gene in UF neuroblastomas. hNLRR-1 was a human homolog of mouse neuronal leucine-rich repeat protein-1 gene whose molecular function has not been clear (Taguchi et al., 1996) . This is the first report of hNLRR-1 as a predominantly expressed gene in unfavorable NBLs. We have also found a new family member of hNLRR in our cDNA libraries, which shows an expression pattern opposite to that of hNLRR-1 (Hamano et al., under preparation). Like Trk family receptors, hNLRR family receptors may play an important role in regulating NBL biology.
Chromosomal mapping of the differentially expressed genes in NBL
To examine the correlation between the differential expression in NBLs and chromosomal rearrangement or epigenetic regulatory loci, we searched for the physical location of the differentially expressed genes by BLAT search of the UC Santa Cruz genome database (http:// genome.ucsc. edu/goldenPath/hgTracks.html). Among 305 candidate genes with the differential expression, 299 independent genes were able to be mapped on chromosomal bands (Figure 3) . Although we expected that the majority of the differentially expressed genes might be mapped on the regions already known to be the loci with loss of heterozygosity (LOH) or amplification, the results were diverse. More than 10% of the genes were mapped on chromosomes 2 (38 genes) and 7 (35 genes). There were some clusters of genes (F4UF) at the loci of 2q31. 1, 5q11.2, 6p22.3, 6q21, 7p15.1, 7q21.11, 7q21.3, 7q31.1, 9q34.2, 11q13.4, 13q13.3, 15q21 .1 and 22q12.2, among which the regions of 2q31.1, 5q11.2 and 9q34.2 were notable. The chromosome 9q34-qter region has been reported to display a high frequency of LOH by Takita et al. (1997) , whereas the former two regions so far have no evidence of high frequency of LOH. On chromosome 9q34.2, three known (one of them was DBH) and one novel gene with high expression in F type NBL (F4UF) were mapped. The chromosomal loci at 1q21-q25, 2p24 and 17q21-q25 have been reported as the regions with amplification or gain of additional chromosomal segments (Plantaz et al., 1997; Bown et al., 1999; Hirai et al., 1999) . Two differentially expressed genes (FoUF) were mapped to 17q23.2-q23.3 and 2p24.2-p24.3, but no such genes were mapped in the 1q arm.
Molecular analysis of the identified genes
To confirm the reliability of our screening system, we performed quantitative real-time RT-PCR of the differentially expressed genes by using 116 primary NBL samples. FOG-2/Nbla03139, one of those genes ( Figure 2 and Table 4), showed significantly higher levels of mRNA expression in average in the tumors with favorable prognosis than in those with unfavorable prognosis, although their expression values ranged widely (Figure 4 ). Seven NBLs with favorable phenotype (4300 e.u., Figure 4 ) exhibited markedly high expression; however, we could not find any other specific clinical characteristics for these cases. Svensson et al. (1999) reported that FOG-2 expression was observed in the heart, brain and testis of the adult mouse, and in the neural epithelium, heart, urogenital ridge and gonad in developing mouse embryo. We also investigated the FOG-2 expression in the parasagittal section of the adult mouse brain (7 weeks) and found that it was expressed in a limited part such as dentate gyrus in hippocampal formation (CA3-CA4) and granule cell layer in the cerebellum (data not shown). Therefore, in addition to the role in heart morphogenesis (Tevosian et al., 1999) , FOG-2 was suggested to play some role in the developing neurons as well as in NBLs. Other novel genes with differential expression between the NBL subsets are currently being subjected to similar analyses. Chromosome-associated protein-E (hCAP-E) F 9
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Discussion
For understanding the molecular basis of neuroblastoma, accumulation and collection of a large number of genes, which may be involved in the neural crest development, neuronal cell growth, differentiation and programmed cell death, is very useful. The recent progress of the Human Genome Project has enabled us to take such an approach in the field of cancer research.
In this study, we generated oligo-capping cDNA libraries from the primary NBL subsets with different clinicobiological characteristics to clone randomly the cDNAs expressed. Our extensive screening for the differentially expressed genes between F and UF subsets of NBL has identified at least 305 such genes, including 194 novel genes with unknown function.
Neuroblastoma cDNA libraries
We have identified the genes with an unknown function in nearly half (40%) of the total 4654 clones from the cDNA libraries we generated, which correspond to 1152 independent novel genes. The expression profile of each library seemed to be quite different supposed from the expression pattern of the known genes. The UF library Category: A ¼ cell signaling, B ¼ cytokine, growth factor, hormones, C ¼ cell cycle, D ¼ cell structure, adhesion, movement, E ¼ transcription, F ¼ DNA replication, DNA repair, DNA synthesis, G ¼ protein synthesis, process, transport, turn over, H ¼ homeostasis, heat-shock protein, metabolic enzymes, I ¼ others, unknown showed a profile of enhanced protein synthesis, and also a high frequency of DDX-1 gene. However, we have found that neither MYCN nor TRKA genes in the clones sequenced. Some of the explanations are that the cDNAs with the specific sequences such as GC-rich regions may be difficult to clone in our oligo-capping cloning system due to an unknown reason and that some genes with GC-rich sequences cannot be DNA sequenced. We indeed missed 411 cDNAs due to impossible sequencing. The lineup of known genes in the F and UF libraries, especially of abundantly expressed genes, indicated that NBLs had a typical pattern of neuronal gene expression profiles. Bodymap (http://bodymap.ims.u-tokyo.ac.jp/) is a human gene expression database, collecting quantitative and qualitative information on gene expression in various tissues or cell types (Okubo et al., 1992) . It utilized a neuroblastoma cell line CHP134 (with MYCN amplification) as a source of neuronal gene expression. In this map, the expression of 14-3-3 epsilon and Ncadherin was also shown to be neuron-specific. However, our present study has added a large number of neuronal genes, including P311 and SCG10 as well as many novel genes.
Screening of the differentially expressed genes
For screening the differentially expressed genes, the methods such as differential display-PCR and serial analysis of gene expression (SAGE) have been applied (McClelland et al., 1995; Velculescu et al., 2000) . These techniques are advantageous because of high throughput and low cost. However, the cloned materials and obtained sequences are very short in length so that it is difficult to obtain a full-length cDNA that is ready for functional analysis. Since our final goal is to identify the important genes expressed differentially between the different subsets of NBL and to clarify their function, we have decided to introduce the method to clone directly as many genes as possible from the cDNA libraries constructed from the primary NBLs. In addition, we have performed semi-quantitative RT-PCR to screen for the differentially expressed genes by using 16 F and 16 UF primary NBL samples. Our Figure 3 Chromosomal location of the genes differentially expressed between the F-and UF-NBL subsets. Arrowheads facing left show the genes preferentially expressed in favorable NBLs, and those facing right show the genes preferentially expressed in unfavorable NBLs Differential screening of neuroblastoma cDNA libraries M Ohira et al 5533 present approach is neither high throughput nor low cost, but the results are consistent. As a result, we have identified 305 independent genes expressed differentially between F and UF subsets, which is a huge number that has so far not been reported. All these genes can be good candidates of new biological and prognostic markers of NBL. Detailed analyses of several differentially expressed genes from this point of view will be described elsewhere (Kawamoto et al., 2003) . The genes related to catecholamine metabolism such as DBH and MAO may also become new prognostic indicators. The downregulation of their expression in the UF tumors seems to support the previously proposed hypothesis that the advanced NBLs with MYCN amplification are dopaminergic with the blockade of a metabolic process from dopamine to noradrenaline (Nakagawara et al., 1988 (Nakagawara et al., , 1990 . Transcription factors and their regulators, such as homeodomain-containing transcription factors and chromatin-modifying molecules, are also important for understanding the biology of NBL subsets. Many other genes that are regulated by those molecules may also be included in the differentially expressed genes.
Differential RT-PCR analysis of methylation-and acetylation-related genes
Our results have shown that the number of genes expressed at high levels in the F subset is about 10 times larger than that in the UF subset (278 vs 27 genes). The following three explanations can be given for this. Firstly, we have used GAPDH expression as a control to adjust and standardize cDNA concentration of F and UF samples because most of the papers so far published have utilized GAPDH as a standard. In this case, there occurs a possibility that the relatively high levels of GAPDH expression is indicated in the UF samples, giving the relatively decreased values of cDNA expression. However, we have used another control gene bactin that has given a result similar to GAPDH.
Secondly, Boon et al. (2001) have reported that the overexpression of MYCN induces the expression of a large set of genes, which involves those related to ribosome biogenesis and protein synthesis. In our study, those genes are also frequently found in the UF library, but they have been excluded from our further study. Thirdly, the yet unknown mechanisms regulating the gene expression may be present between the two subsets. For example, the epigenetic regulation, including chromosomal methylation or histone acetylation, could be present. Therefore, in the preliminary study, we have examined whether or not the genes regulating DNA methylation or histone acetylation are differentially expressed between F and UF subsets of NBL. However, none of the methylation-related genes (DNMT1,2,3, MBD1,2,3,4 and MeCP2) have displayed differential expression (Furuya et al., unpublished data) . On the other hand, some members of histone acetylationrelated genes (CBP and HAT1) have shown a pattern of differential expression to a certain extent, suggesting the presence of different epigenetic regulation in the gene expression between the subsets (Furuya et al., in preparation). Several recent reports have shown that the epigenetically regulated genes in cancers and other hereditary diseases often cluster in continuous regions (Mitsuya et al., 1999; Okutsu et al., 2000; Ono et al., 2001) . In our present data, some clusters of the F4UF genes have been found in chromosomes 2, 5, 6, 7, 9, 11, 13, 15 and 22, suggesting the existence of the epigenetically regulated chromosomal loci in NBLs.
In conclusion, our NBL cDNA project has provided us with 2313 known genes and 1799 novel genes with an unknown function, among which 111 known and 194 novel genes are differentially expressed between F and UF subsets of NBL. This huge number of cDNA resources may become an important tool to unveil the molecular mechanism of the enigmatic clinical behavior of NBL, as well as to develop new diagnostic and therapeutic strategies against the aggressive tumors in the future. We are currently expanding this cDNA project to the stage 4s NBL and applying the clones to the cDNA microarray system.
Materials and methods

Tissues and cell lines
Fresh, frozen tumor tissues were sent to the Division of Biochemistry, Chiba Cancer Center Research Institute, from various hospitals in Japan. The tumors were staged according to the International Neuroblastoma Staging System. (stages 1 and 2, localized neuroblastomas; stages 3 and 4, locally and regionally growing and distantly metastatic neuroblastomas; and stage 4s, neuroblastomas in children under 1 year of age, with metastases restricted to the skin, liver and bone marrow, usually regressing spontaneously) . In Japan, a mass screening program for infants at the age of 6 months has been performed since 1984. Patients found by this screening have been mostly classified into the early stage of the disease, although a small proportion had unfavorable prognoses (Sawada et al., 1984 (Seeger et al., 1985; Bartram and Berthold, 1987; Nakagawara et al., 1987 Nakagawara et al., , 1992 Nakagawara et al., , 1993 Slavc et al., 1990; Look et al., 1991; Brodeur et al., 1993) . High molecular weight DNA and total RNA of these samples were prepared as described previously (Ichimiya et al., 1999) .
cDNA library construction
Oligo-capping cDNA libraries (Maruyama and Sugano, 1994; Suzuki et al., 1997) were constructed from the mixture of three-stage 1 NBL frozen tissues with a single copy of MYCN (favorable subset) and from that of three NBL frozen tissues in stages 3 and 4 with MYCN amplification (unfavorable subset). They were approved by the institutional review board.
Sequencing and classification of cDNA clones
Independent clones from two subsets of libraries were randomly picked up and sequenced from both ends. The end sequences of 2410 clones obtained from the favorable NBL library and those of 2244 clones from the unfavorable NBL library were then homology searched against public databases (Genbank release 122, January 2001) using Cybergate sequence classification system (Dynacom Inc.) and bundled into gene clusters by assembling sequences. The end sequences that included a novel sequence were submitted to DDBJ/ GenBank nucleotide database (Accession no. AU252405-AU254042).
Differential screening of the genes by semiquantitative RT-PCR
Typical 16 samples from each NBL subset were selected as PCR templates to screen for the differentially expressed genes. All 16 tumors with the favorable biology were defined as stage 1 NBLs with no MYCN amplification, but with a high expression of TrkA. The 16 tumors with unfavorable biology were in stage 3 or 4, exhibiting MYCN amplification and low TrkA expression. The differential expression of the genes between the NBL subsets was confirmed at least twice using semiquantitative RT-PCR. The individual gene-specific PCR primer sequences were determined by using Primer3 program (provided at Washington University). For cDNA templates, 5 mg of total RNA was converted into cDNA using random primers (Takara, Otsu, Japan) with SuperScript II RNaseH -reverse transcriptase (Gibco BRL, Rockville, MD, USA).
Those cDNAs were at first amplified with Cy5-labeled GAPDH primers in 25 cycles and the amounts of PCR products were measured by ALF Expresst sequencer and normalized. The amplification was performed as follows: 35 cycles of 941C for 30 s, 611C for 15 s and 721C for 60 s, and the final extension was at 721C for 5 min, using a Perkin Elmer Thermalcycler 9700 (Perkin-Elmer, Foster City, CA, USA). The PCR products were run on 2% agarose gels and stained with ethidium bromide.
Quantification of genes expression by real-time RT-PCR
Real-time RT-PCR was performed in triplicates to quantify the amounts of genes expressed in the primary neuroblastomas (Abe et al., 1999; Inoue et al., 1999) . The reaction was performed using a PCR core reagent kit with an ABI 7700 sequence detector system (Perkin-Elmer, Foster City, CA, USA). Five micrograms of total RNA was converted into cDNA using random primers with SuperScript II reverse transcriptase and diluted by 20-fold. The reaction mixtures (25 ml) contained 2 ml of cDNA solution, 2.5 ml of 10 Â Taq Man buffer A, 200 mm dATP, 200 mm dCTP, 200 mm dGTP, 400 mm dUTP, 3.5 mm MgCl2, 300 nm forward primer, 300 nm reverse primer, 300 nm Taq Man probe, 0.625 U of Ampli Taq Gold DNA polymerase and 0.25 U of Amp Erase uracil Nglycosylase (UNG) (Perkin-Elmer). The thermal cycling conditions were as follows: initial activation of UNG at 501C for 2 min followed by activation of Ampli Taq Gold and inactivation of UNG at 951C for 10 min, and subsequently, 40 cycles of amplification were performed at 951C for 15 s and 601C for 1 min. The amount of GAPDH mRNA in all samples was measured by real-time RT-PCR as a control using Taq Man GAPDH Control Reagents (Roche Molecular Systems, Inc., Branchburg, NJ, USA).
